Clinical trial · Observational
Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer
NCT06827340CI-TRIAL-00086000completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
WB-MRI is a next-generation imaging technique standardized with the first version of MET-RADs-P guidelines.This narrative review aims to analyse the main scientific evidence available in the literature, explaining what WB MRI is and showing its decisive role in metastatic PC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer (Adenocarcinoma) | Malignant Prostate Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (6)
- measure
- Identifying the imaging features of metastatic PC in WB-MRI
- timeFrame
- from 1995 to april 2024
- measure
- Evaluation of Bone Metastases with WB-MRI
- timeFrame
- from 1995 to April 2024
- measure
- Assessment of Nodal Disease
- timeFrame
- from 1995 to april 2024
- measure
- Assessment of Visceral Disease
- timeFrame
- from 1995 to april 2024
- measure
- Assessing Local Disease and Biochemical Recurrence
- timeFrame
- from 1995 to april 2024
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Literature extracted through the PubMed search engine, following PRISMA checklist, using the keywords: * "Whole Body MRI" * "Diffusion Weighted Imaging" * "PET-CT and WB-MRI" * "Metastatic Prostate Cancer" * "Biochemical Recurrence in Metastatic Prostate Cancer" * "DWIBS" * "Multiparametric MRI" * "response assessment in metastatic prostate cancer" * "Dixon Method", * "bone biopsy in metastatic prostate cancer", * "bone metastases in prostate cancer", * "MET-RADs". * analysis from 1995 to April 2024. Exclusion Criteria: * duplicates * repetitive, * irrelevant, * unrelated, * out-of-date guidelines, * case reports
References
Publications (0)
Data not yet available
No reference posted for this study.